Invitae Responds Being Names as Defendant in Myriad Genetics Lawsuit

Invitae Corporation today announced that it plans to defend its right to provide naturally occurring genetic information and services to physicians for their cancer patients through … Invitae Corporation today announced that it plans to defend its right to provide naturally occurring genetic information and services to physicians for their cancer patients through its genetic testing services. Invitae has been named a defendant in a lawsuit filed by Myriad Genetics

regarding Invitae's BRCA and MUTYH genetic tests. Invitae disagrees with the allegations of the lawsuit and plans to vigorously defend itself against the lawsuit, which it believes has no merit. Earlier this year, the Supreme Court ruled that naturally occurring DNA and the information it encodes cannot be patented (Assn'n for Molecular Pathology v. Myriad Genetics, Inc., 133 S. Ct. 2107 [2013]) and thus ushered in a